摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(2R,3S,4R,5R,6R)-3,4-diacetyloxy-6-(2,2,2-trichloroethanimidoyl)oxy-5-[[4-(trifluoromethyl)phenyl]methylideneamino]oxan-2-yl]methyl acetate | 1163723-37-2

中文名称
——
中文别名
——
英文名称
[(2R,3S,4R,5R,6R)-3,4-diacetyloxy-6-(2,2,2-trichloroethanimidoyl)oxy-5-[[4-(trifluoromethyl)phenyl]methylideneamino]oxan-2-yl]methyl acetate
英文别名
——
[(2R,3S,4R,5R,6R)-3,4-diacetyloxy-6-(2,2,2-trichloroethanimidoyl)oxy-5-[[4-(trifluoromethyl)phenyl]methylideneamino]oxan-2-yl]methyl acetate化学式
CAS
1163723-37-2
化学式
C22H22Cl3F3N2O8
mdl
——
分子量
605.779
InChiKey
GXECMZKKXCSUAR-FVVUREQNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    38
  • 可旋转键数:
    11
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    134
  • 氢给体数:
    1
  • 氢受体数:
    13

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    甲基2,3,6-三-O-苄基-ALPHA-D-吡喃葡萄糖苷[(2R,3S,4R,5R,6R)-3,4-diacetyloxy-6-(2,2,2-trichloroethanimidoyl)oxy-5-[[4-(trifluoromethyl)phenyl]methylideneamino]oxan-2-yl]methyl acetate 在 2CF3O3S(1-)*C28H16F4N4Ni(2+) 作用下, 以 二氯甲烷 为溶剂, 以84%的产率得到[(2R,3S,4R,5R,6R)-3,4-diacetyloxy-6-[(2R,3R,4S,5R,6S)-6-methoxy-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)oxan-3-yl]oxy-5-[[4-(trifluoromethyl)phenyl]methylideneamino]oxan-2-yl]methyl acetate
    参考文献:
    名称:
    镍催化立体选择性糖基化与 C(2)-N-取代的亚苄基氨基葡萄糖和半乳糖胺三氯乙酰亚胺酸盐形成 1,2-顺-2-氨基糖苷。在肝素二糖、GPI 锚定假二糖和 α-GalNAc 合成中的应用
    摘要:
    1,2-cis-2-amino glycosides 是在各种生物学上重要的寡糖和糖肽中发现的关键成分。尽管 1,2-cis-2-氨基糖苷的合成取得了显着进展,但目前最先进方法的缺点包括底物范围有限、产率低、反应时间长和异头混合物。我们开发了一种通过镍催化的 α-选择性糖基化与 C(2)-N-取代的亚苄基 D-葡糖胺和半乳糖胺三氯乙酰亚胺合成 1,2-顺-2-氨基糖苷的新方法。这些糖基供体能够与多种醇偶联,以高产率提供具有出色 α 选择性的糖缀合物。此外,仅需要亚化学计量的镍 (5-10 mol%) 才能在 25 °C 下进行反应。目前的镍方法依赖于镍配体配合物的性质来控制 α 选择性。亲核试剂的反应位点或保护基团的性质对α-选择性几乎没有影响。该方法也已成功应用于二糖供体和受体,以高产率和 α 选择性提供相应的寡糖。镍过程的功效已进一步应用于制备肝素二糖、GPI 锚定假二糖和 α-Glu
    DOI:
    10.1021/ja106682m
点击查看最新优质反应信息

文献信息

  • Studies on the Selectivity Between Nickel-Catalyzed 1,2-<i>cis</i>-2-Amino Glycosylation of Hydroxyl Groups of Thioglycoside Acceptors with C(2)-Substituted Benzylidene <i>N</i>-Phenyl Trifluoroacetimidates and Intermolecular Aglycon Transfer of the Sulfide Group
    作者:Fei Yu、Hien M. Nguyen
    DOI:10.1021/jo301050q
    日期:2012.9.7
    glycoconjugates bearing the 1,2-cis-2-amino glycosidic linkages because the saccharide thioglycosides obtained can serve as donors for another coupling iteration. This approach streamlines selective deprotection and anomeric derivatization steps prior to the subsequent coupling event. We have developed an efficient approach for the synthesis of highly yielding and α-selective saccharide thioglycosides containing
    包含 1,2-顺式-2-基糖苷键的糖糖苷的立体选择性合成具有挑战性。除了在 1,2-顺式-2-基糖苷键形成中实现高α-选择性的困难之外,糖基化反应还受到异头硫化物基团从糖基受体到糖基供体的不希望的转移的阻碍。克服这些障碍将为制备带有 1,2-顺式分子的寡糖和糖缀合物铺平道路。-2-基糖苷键,因为获得的糖糖苷可以作为另一次偶联迭代的供体。这种方法在随后的偶联事件之前简化了选择性去保护和异头衍生化步骤。我们开发了一种有效的方法来合成含有 1,2-顺式-2-基糖苷键的高产率和 α-选择性糖糖苷,通过阳离子催化的带有 2-三甲基苯基苷元的糖苷受体的糖基化与N-苯基三酰亚胺酯供体。2-三甲基苯基有效地阻止异头硫化物基团从糖基受体转移到 C(2)-亚苄基供体,并且易于安装和激活。目前的方法还突出了催化剂在糖基受体上存在异头硫化物基团的情况下选择性活化 C(2)-亚苄基亚胺酯基团的功效。
  • Nickel-catalyzed α-glycosylation of C(1)-hydroxyl<scp>d</scp>-myo-inositol: a formal synthesis of mycothiol
    作者:Matthew S. McConnell、Fei Yu、Hien M. Nguyen
    DOI:10.1039/c2cc35823a
    日期:——
    Formal synthesis of mycothiol has been developed via nickel-catalyzed α-glycosylation of the C(1)-hydroxyl group of D-myo-inositols with C(2)-N-substituted benzylideneamino N-phenyl trifluoroacetimidate donors. The pseudo-oligosaccharides were obtained in good yield and with excellent α-selectivity. Removal of the C(2)-N-2-trifluoromethylphenyl-benzylidene group under mild conditions provides a pseudo-disaccharide, completing the formal synthesis of mycothiol.
    mycothiol 的正式合成是通过催化 D-myo-肌醇的 C(1)-羟基与 C(2)-N-取代的亚苄基基 N-苯基三酰亚胺酯供体的 α-糖基化来开发的。所获得的假低聚糖具有良好的产率和优异的α选择性。在温和条件下去除C(2)-N-2-三甲基苯基-亚苄基基团提供假二糖,完成菌醇的正式合成。
  • Nickel-Catalyzed Stereoselective Formation of α-2-Deoxy-2-Amino Glycosides
    作者:Enoch A. Mensah、Hien M. Nguyen
    DOI:10.1021/ja903123b
    日期:2009.7.1
    The development of a new method for the stereoselective synthesis of alpha-2-deoxy-2-amino glycosides is described. This methodology relies on the nature of the cationic nickel catalyst, generated in situ from L0NiCl2 and AgOTf, to direct the anomeric stereoselectivity. The new glycosylation reaction is highly a-selective and proceeds under mild conditions with 5-10 mol % of the nickel catalyst Loading at ambient temperature. This new method has been applied to both D-glucosamine and galactosamine trichloroacetimidate donors as well as an array of primary, secondary, and tertiary alcohol nucleophiles to provide the desired glycoconjugates in good yields with excellent alpha-selectivity. Mechanistic studies of the present reaction are underway and will be reported in due course.
  • Stereoselective α-glycosylation of C(6)-hydroxyl myo-inositols via nickel catalysis—application to the synthesis of GPI anchor pseudo-oligosaccharides
    作者:Matthew S. McConnell、Enoch A. Mensah、Hien M. Nguyen
    DOI:10.1016/j.carres.2013.09.006
    日期:2013.11
    Glycosylphosphatidyl inositol (GPI) anchors play a key role in many eukaryotic biological pathways. Stereoselective synthesis of GPI anchor analogues have proven to be critical for probing the biosynthesis, structure, and biological properties of these compounds. Challenges that have emerged from these efforts include the preparation of the selectively protected myo-inositol building blocks and the stereoselective construction of glucosamine alpha-linked myo-inositol containing pseudodisaccharide units. Herein, we describe the effectiveness of the cationic nickel(II) catalyst, Ni(4-F-PhCN)(4)(OTf)(2), at promoting selective formation of 1,2-cis-2-amino glycosidic bonds between the C(2)-N-substituted benzylideneamino trihaloacetimidate donors and C(6)-hydroxyl myo-inositol acceptors. This catalytic coupling process allows rapid access to pseudosaccharides of GPI anchors in good yields and with excellent levels of a-selectivity (alpha:beta = 10:1-20:1). In stark contrast, activation of trichloroacetimidate donors containing the C(2)-N-substituted benzylidene group with TMSOTf and BF3.OEt2 provided the desired pseudodisaccharides as a 1: 1 mixture of alpha- and beta-isomers. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-2,2'',3,3''-四氢-6,6''-二-9-菲基-1,1''-螺双[1H-茚]-7,7''-二醇 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (6,6)-苯基-C61己酸甲酯 (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2′′-甲基氨基-1,1′′-联苯-2-基)甲烷磺酰基铝(II)二聚体 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环